WORLD MEDICAL INNOVATION FORUM NEUROSCIENCES Boston, Massachusetts April 27-29, 2015 WMIF2015@partners.org The World Medical Innovation Forum features CEOs of industry-leading multinational medical companies, Partners HealthCare top clinicians and scientists—all Harvard Medical School faculty members—and
WORLD MEDICAL INNOVATION FORUM
April 27-29, 2015
The World Medical Innovation Forum features CEOs of industry-leading multinational medical companies, Partners HealthCare top clinicians and scientists—all Harvard Medical School faculty members—and global technology leaders. Join 1,000 international innovation decision-makers and be briefed on the state of the art in neuroscience technology, care and research directly from the CEOs bringing game-changing products to market, world-class clinicians delivering the highest-quality care and the scientists rapidly propelling this crucial field forward through their CNS insights and discoveries. Additionally, the industry-wide issues driving investment, application and reimbursement of innovation during this period of profound transformation in healthcare will be debated.
Disruptive technologies in genomics, imaging and informatics are driving fundamental change in the American health care system at the same time it is being transformed from volume-based care toward one organized around value, patient outcomes and sustained health. In the neurosciences, a series of new technologies are challenging long-accepted limits of diagnosis and care while population health initiatives are changing management of chronic neurologic and psychiatric disease.
Chief executives of some of the largest and most important companies in health care, including GE, Novartis, Amgen, Biogen Idec, Boston Scientific, Vertex Pharmaceuticals and dozens of other CEOs will join Harvard clinical and research faculty— all leading physicians and scientists from Brigham and Women’s Hospital (BWH), Massachusetts General Hospital (MGH) and McLean Hospital, including Atul Gawande, MD, and Rudy Tanzi, PhD—and investors, entrepreneurs, senior government executives, corporate officers and top journalists in the World Forum’s two-and-a-half-day gathering.
The inaugural World Medical Innovation Forum will be held in Boston April 27-29, 2015. Current and emerging approaches to diagnosing and caring for neurologic and psychiatric disorders will be highlighted, including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, depression, schizophrenia, autism, stroke and sleep disorders. Also, game-changing diagnostic tools and therapeutic interventions will be presented, including genome editing, gene therapy, neurostimulation, neuroregeneration, population management, neuroimaging and novel biomarkers.
The World Forum is organized around one clinical field per year—neurosciences in 2015 followed by cancer in 2016. The annual Forum provides attendees and policy makers with actionable insights into the torrent of new technology in the neurosciences and the swiftly evolving business of health care innovation. Attendees are senior executives of large companies, investors, entrepreneurs and officers of venture-backed companies, business-minded clinicians and investigators, government principals and dealmakers. Participants include a significant complement of international leaders and organizations.
april 27 (Monday) - 29 (Wednesday)
Nutter McClennen & Fish, LLP, Seaport West
155 Seaport Blvd Boston,MA 02210 USA